548 Results

People

  1. Rossi
    Rossi
  2. Dee
    Dee
  3. Marghoob
    Marghoob
  4. Dogan
    Dogan
  5. Dusza
    Dusza
  6. Giralt
    Giralt
  7. Perales
    Perales
  8. Marchetti
    Marchetti
  9. Nehal
    Nehal
  10. Salles
    Salles

Groups

  1. Department of Medicine (301)
  2. Hematologic Malignancies, Division of (169)
  3. Center for Hematologic Malignancies (151)
  4. Sloan Kettering Institute Postdocs (133)
  5. Survivorship Research (132)
  6. Division of Subspecialty Medicine (121)
  7. Population Sciences Research Program (116)
  8. GSK Faculty (96)
  9. Dermatology Service (87)
  10. Dermatology (86)
  1. "Research letter"
Formats
  1. Research Letter (548)
Groups
  1. Department of Medicine (301)
  2. Hematologic Malignancies, Division of (169)
  3. Center for Hematologic Malignancies (151)
  4. Sloan Kettering Institute Postdocs (133)
  5. Survivorship Research (132)
  6. Division of Subspecialty Medicine (121)

More Groups

People
  1. Anthony Rossi (23)
  2. Edward Christopher Dee (21)
  3. Ashfaq Marghoob (19)
  4. Ahmet Dogan (18)
  5. Michael Marchetti (18)
  6. Miguel-Angel Perales (17)

More People

Years
  1. 2025 (42)
  2. 2024 (89)
  3. 2023 (101)
  4. 2022 (82)
  5. 2021 (91)
  6. 2020 (95)

More Years

Publications
  1. Journal of the American Academy of Dermatology (46)
  2. Blood Advances (31)
  3. Haematologica (25)
  4. Leukemia (25)
  5. Bone Marrow Transplantation (18)
  6. American Journal of Hematology (17)

More Publications

Publishers
  1. Nature Publishing Group (97)
  2. Mosby Elsevier (49)
  3. American Medical Association (45)
  4. American Society of Hematology (44)
  5. Wiley Blackwell (34)
  6. Elsevier Inc. (29)

More Publishers

Results (548)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Enhancing protein-ligand binding affinity predictions using neural network potentials
    Research Letter

    Sabanés Zariquiey, F.; Galvelis, R.; Gallicchio, E.; Chodera, J. D.; Markland, T. E.; De Fabritiis, G.
    Journal of Chemical Information and Modeling (2024)

    Fulltext@MSK | Save
  • Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1
    Research Letter

    Crosswell, H. E.; LaCasce, A. S.; Bartlett, N. L.; Straus, D. J.; Savage, K. J.; Zinzani, P. L.; Collins, G. P.; Fanale, M.; Fenton, K.; Dong, C.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Continuing medical education-accredited reflectance confocal microscopy course in the USA and its impact on learning and clinical integration: Report from a single centre
    Research Letter

    Navarrete-Dechent, C.; Rajadhyaksha, M.; Marghoob, A. A.; Nehal, K. S.; Halpern, A. C.; Rossi, A. M.; Jain, M.
    Clinical and Experimental Dermatology (2024)

    Fulltext@MSK | Save
  • Acute myeloid leukemia stratifies as 2 clinically relevant sphingolipidomic subtypes
    Research Letter

    Paudel, B. B.; Tan, S. F.; Fox, T. E.; Ung, J.; Golla, U.; Shaw, J. J. P.; Dunton, W.; Lee, I.; Fares, W. A.; Patel, S.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Advanced melanoma presentation and disease-specific survival disparities among disaggregated Asian American, Native Hawaiian, and Pacific Islander populations
    Research Letter

    Kim, D. Y.; Dee, E. C.; Cheng, I.; Hartman, R. I.
    Journal of the American Academy of Dermatology (2024)

    Fulltext@MSK | Save
  • Temporal trends in guideline-recommended cardiometabolic testing completeness before initiating immune checkpoint inhibitors: A cohort study
    Research Letter

    Chan, J. S. K.; Chou, O. H. I.; Lee, T. T. L.; Lee, Y. H. A.; Chan, R. N. C.; Dee, E. C.; Ng, K.; Liu, T.; Tse, G.
    Journal of Internal Medicine (2024)

    Fulltext@MSK | Save
  • Association of previously irradiated stable brain metastases with outcomes of atezolizumab-treated non-small cell lung cancer: A pooled analysis of individual patient data from three randomized trials
    Research Letter

    Guo, T.; Zhou, Y.; Liang, F.; Wang, Z.; Bourbonne, V.; Käsmann, L.; Sundahl, N.; Jing-Ching Wu, A.; Ni, J.; Zhu, Z.
    Cancer Communications (2024)

    Fulltext@MSK | Save
  • Gemcitabine plus pembrolizumab after checkpoint blockade failure as a strategy in multiply relapsed Hodgkin lymphoma
    Research Letter

    Stuver, R.; Noy, A.; Vardhana, S. A.; Zelenetz, A. D.; Moskowitz, A. J.
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Association of exercise with pan-cancer incidence and overall survival
    Research Letter

    Lavery, J. A.; Boutros, P. C.; Knight, D.; Tammela, T.; Moskowitz, C. S.; Jones, L. W.
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: Results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
    Research Letter

    Badar, T.; Nanaa, A.; Atallah, E.; Shallis, R. M.; Guilherme, S. D. C. C.; Goldberg, A. D.; Saliba, A. N.; Patel, A.; Bewersdorf, J. P.; DuVall, A. S.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save